It was discovered that SPC24 is abnormally expressed in a variety of diseases including neoplastic diseases, and SPC24 may act as an oncogene in kidney cancer via regulation of SRY-box transcription factor 2 (12). This evidence concerns the gene SPC24 and kidney cancer.